11th Circ. Denies Cert. Appeal In $867M Astellas Antitrust Suit
The 11th Circuit refused Thursday to let a Florida hospital appeal in hopes of winning certification of an $867 million antitrust class action accusing Astellas Pharma Inc. of improperly requiring use...To view the full article, register now.
Already a subscriber? Click here to view full article